Thiraporn Kanjanaphan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Thiraporn Kanjanaphan has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Ornatcha Sirimongkolchaiyakul
Division of Nephrology, Department of Pediatrics, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand
2 shared publicationsChutima Chavanisakun
Department of Anatomical Pathology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand
1 shared publication- Daranee Isaranimitkul
Vajira Hospital, Navamindradhiraj University Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine Bangkok, Thailand
1 shared publication - Krit Cheawcharnprapan
Vajira Hospital, Navamindradhiraj University Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine Bangkok, Thailand
1 shared publication Krit Cheawcharnpraparn
Division of Neurology, Department of Pediatrics, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand
1 shared publicationMaysa Pattrayuttawat
Department of Pediatrics, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand
1 shared publication
Latest Publications
- Open Access
- 20 March 2026
- Published by Faculty of Medicine Vajira Hospital, Navamindradhiraj University in Journal of Medicine and Urban Health
- p. e7425
Mpox in Neonates and Children: A Review Article
Mpox, caused by the monkeypox virus, has expanded beyond its historical African boundaries, with significant global outbreaks, including a 2022 surge. While traditionally affecting adults, recent cases in neonates and children show more severe complications, including respiratory failure, encephalitis, and sepsis. Children are more vulnerable due to an immature immune system and at higher risk for multi-organ involvement. Prevention focuses on vaccination, personal hygiene, and safe sexual practices, with JYNNEOS® and ACAM2000® vaccines recommended for high-risk groups. Early diagnosis, supportive care, and antiviral treatment are crucial in managing severe cases. This review highlights differences in disease severity between adults and children and outlines key prevention and treatment strategies
- 20 March 2026
- Published by Faculty of Medicine Vajira Hospital, Navamindradhiraj University in Journal of Medicine and Urban Health
- p. e7425
Open AccessMpox in Neonates and Children: A Review Article
Mpox, caused by the monkeypox virus, has expanded beyond its historical African boundaries, with significant global outbreaks, including a 2022 surge. While traditionally affecting adults, recent cases in neonates and children show more severe complications, including respiratory failure, encephalitis, and sepsis. Children are more vulnerable due to an immature immune system and at higher risk for multi-organ involvement. Prevention focuses on vaccination, personal hygiene, and safe sexual practices, with JYNNEOS® and ACAM2000® vaccines recommended for high-risk groups. Early diagnosis, supportive care, and antiviral treatment are crucial in managing severe cases. This review highlights differences in disease severity between adults and children and outlines key prevention and treatment strategies
- 30 December 2025
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 34 (2)
Risk Factors for Severe Influenza in Children
Introduction: Influenza poses a significant risk of mortality among pediatric patients. However, the specific risk factors associated with severe influenza in children are not well-defined. Clarifying these factors is crucial for improving preventive strategies against infection. Methods: This retrospective study analyzed pediatric patients under 15 years old who were diagnosed with influenza infection at Vajira Hospital from January 1, 2018, to December 31, 2022. Multivariate analysis was utilized to identify factors associated with severe influenza. Results: The 5-year retrospective study revealed that 300 pediatric patients were diagnosed with influenza infection. The median age was 4 months (interquartile range, 2.00–8.75 months), with 50% of patients being female. Among them, 80 patients (26.67%) had underlying diseases, with chronic lung disease being the most prevalent (22 patients, 7.33%). Notably, 94% of the patients had not received the influenza vaccine. Severe influenza was found in 56 patients (18.67%). Underlying diseases (odds ratio, 7.37; P < 0.001), especially chronic lungs disease (adjusted odds ratio, 45.286; P < 0.001) and nosocomial infection (adjusted odds ratio, 3.29; P = 0.019) were identified as factors associated with severe influenza. Conclusions: One-fifth of pediatric influenza cases exhibited severe manifestations, with underlying diseases and nosocomial infection identified as significant risk factors for severe influenza. Close monitoring is warranted for these patients, and infection control measures should be emphasized to prevent nosocomial infections.
- 30 December 2025
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 34 (2)
Risk Factors for Severe Influenza in Children
Introduction: Influenza poses a significant risk of mortality among pediatric patients. However, the specific risk factors associated with severe influenza in children are not well-defined. Clarifying these factors is crucial for improving preventive strategies against infection. Methods: This retrospective study analyzed pediatric patients under 15 years old who were diagnosed with influenza infection at Vajira Hospital from January 1, 2018, to December 31, 2022. Multivariate analysis was utilized to identify factors associated with severe influenza. Results: The 5-year retrospective study revealed that 300 pediatric patients were diagnosed with influenza infection. The median age was 4 months (interquartile range, 2.00–8.75 months), with 50% of patients being female. Among them, 80 patients (26.67%) had underlying diseases, with chronic lung disease being the most prevalent (22 patients, 7.33%). Notably, 94% of the patients had not received the influenza vaccine. Severe influenza was found in 56 patients (18.67%). Underlying diseases (odds ratio, 7.37; P < 0.001), especially chronic lungs disease (adjusted odds ratio, 45.286; P < 0.001) and nosocomial infection (adjusted odds ratio, 3.29; P = 0.019) were identified as factors associated with severe influenza. Conclusions: One-fifth of pediatric influenza cases exhibited severe manifestations, with underlying diseases and nosocomial infection identified as significant risk factors for severe influenza. Close monitoring is warranted for these patients, and infection control measures should be emphasized to prevent nosocomial infections.
- Open Access
- 31 October 2024
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 22 (1) , 1-10
Epstein–Barr Virus encephalitis associated hemophagocytic lymphohistiocytosis in childhood-onset systemic lupus erythematosus: a case-based review
Hemophagocytic lymphohistiocytosis (HLH) is characterized by immune dysregulation that results in an uncontrolled hyperinflammatory state. HLH is classified into two main categories: primary (familial) HLH and secondary (acquired) HLH. Secondary HLH can result from various underlying, including infection-associated hemophagocytic syndrome (IAHS) and macrophage activation syndrome (MAS) associated with rheumatologic disorders, among others. Epstein–Barr virus (EBV) often causes IAHS, but central nervous system (CNS) involvement is rare among systemic lupus erythematosus (SLE) patients. We report a case of EBV encephalitis associated with HLH in a patient with childhood-onset SLE. A 12-year-old girl had received a diagnosis of SLE 2 months before presentation. After a period of inactive disease on treatment, fever and seizures, with altered mental status and hallucinations, developed over several weeks. A complete blood cell count (CBC) revealed pancytopenia, accompanied by elevated levels of inflammatory markers: 86 mm/hr erythrocyte sedimentation rate, 8.9 mg/dl c-reactive protein, and 3,966 ng/mL of ferritin. The differential diagnosis included active neuropsychiatric SLE, CNS infection and neurological manifestations in secondary HLH, which could have represented either IAHS or MAS. Meropenem and acyclovir were initially administered for clinical acute encephalitis, followed by pulse methylprednisolone; however, the fever persisted, and another CBC revealed progressive cytopenia. A bone marrow study showed hypocellularity and active hemophagocytic activity, and intravenous immunoglobulin was additionally given due to the diagnosis of HLH. Cerebrospinal fluid (CSF) analysis showed 60/mm3 white blood cells (N 55%, L 45%), 141 mg/dL glucose (0.7 blood-CSF glucose ratio), < 4 mg/dL protein; results of Gram stain and bacterial culture were negative. The viral encephalitis panel from the CSF confirmed EBV infection. Bone marrow immunohistochemistry examination revealed increasing levels of CD8 + T-cell and equivocal positive results for EBV-encoded RNA in situ hybridization; therefore, HLH potentially associated with EBV was diagnosed. After treatment with IVIg, cyclosporin A, and prednisolone, the patient’s symptoms gradually improved and she was eventually able to return to school. Our case highlights the importance of a thorough differential diagnosis, including EBV encephalitis associated with HLH, in patients with childhood SLE, particularly in cases of clinical deterioration occurs after initial treatment.
- 31 October 2024
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 22 (1) , 1-10
Open AccessEpstein–Barr Virus encephalitis associated hemophagocytic lymphohistiocytosis in childhood-onset systemic lupus erythematosus: a case-based review
Hemophagocytic lymphohistiocytosis (HLH) is characterized by immune dysregulation that results in an uncontrolled hyperinflammatory state. HLH is classified into two main categories: primary (familial) HLH and secondary (acquired) HLH. Secondary HLH can result from various underlying, including infection-associated hemophagocytic syndrome (IAHS) and macrophage activation syndrome (MAS) associated with rheumatologic disorders, among others. Epstein–Barr virus (EBV) often causes IAHS, but central nervous system (CNS) involvement is rare among systemic lupus erythematosus (SLE) patients. We report a case of EBV encephalitis associated with HLH in a patient with childhood-onset SLE. A 12-year-old girl had received a diagnosis of SLE 2 months before presentation. After a period of inactive disease on treatment, fever and seizures, with altered mental status and hallucinations, developed over several weeks. A complete blood cell count (CBC) revealed pancytopenia, accompanied by elevated levels of inflammatory markers: 86 mm/hr erythrocyte sedimentation rate, 8.9 mg/dl c-reactive protein, and 3,966 ng/mL of ferritin. The differential diagnosis included active neuropsychiatric SLE, CNS infection and neurological manifestations in secondary HLH, which could have represented either IAHS or MAS. Meropenem and acyclovir were initially administered for clinical acute encephalitis, followed by pulse methylprednisolone; however, the fever persisted, and another CBC revealed progressive cytopenia. A bone marrow study showed hypocellularity and active hemophagocytic activity, and intravenous immunoglobulin was additionally given due to the diagnosis of HLH. Cerebrospinal fluid (CSF) analysis showed 60/mm3 white blood cells (N 55%, L 45%), 141 mg/dL glucose (0.7 blood-CSF glucose ratio), < 4 mg/dL protein; results of Gram stain and bacterial culture were negative. The viral encephalitis panel from the CSF confirmed EBV infection. Bone marrow immunohistochemistry examination revealed increasing levels of CD8 + T-cell and equivocal positive results for EBV-encoded RNA in situ hybridization; therefore, HLH potentially associated with EBV was diagnosed. After treatment with IVIg, cyclosporin A, and prednisolone, the patient’s symptoms gradually improved and she was eventually able to return to school. Our case highlights the importance of a thorough differential diagnosis, including EBV encephalitis associated with HLH, in patients with childhood SLE, particularly in cases of clinical deterioration occurs after initial treatment.
- Open Access
- 18 March 2024
- Published by MedCrave Group Kft. in Journal of Pediatrics & Neonatal Care
- Vol. 14 (1) , 60-61
Unveiling the emerging of fluconazole-resistant Candida albicans in preterm with acute kidney injury: a growing challenge at Vajira hospital
This case presents a challenging scenario in a preterm female newborn born at 25 weeks gestation,who developed respiratory distress syndrome, followed by pneumonia, sepsis, subsequent renal complications, and candida albicans infection. Despite initial susceptibility to fluconazole, the emergence of fluconazole-resistant candida albicans led to a shift in antifungal treatment to amphotericin B in an acute kidney injury neonate. This case underscores the growing concern of drug-resistant candida albicans in neonates, highlighting the importance of judicious selection of empirical antifungal therapy and comprehensive management strategies, especially in the context of acute kidney injury.
- 18 March 2024
- Published by MedCrave Group Kft. in Journal of Pediatrics & Neonatal Care
- Vol. 14 (1) , 60-61
Open AccessUnveiling the emerging of fluconazole-resistant Candida albicans in preterm with acute kidney injury: a growing challenge at Vajira hospital
This case presents a challenging scenario in a preterm female newborn born at 25 weeks gestation,who developed respiratory distress syndrome, followed by pneumonia, sepsis, subsequent renal complications, and candida albicans infection. Despite initial susceptibility to fluconazole, the emergence of fluconazole-resistant candida albicans led to a shift in antifungal treatment to amphotericin B in an acute kidney injury neonate. This case underscores the growing concern of drug-resistant candida albicans in neonates, highlighting the importance of judicious selection of empirical antifungal therapy and comprehensive management strategies, especially in the context of acute kidney injury.
- Open Access
- 1 August 2023
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2023 (8) , 295-297
Aspergillosis and pulmonary tuberculosis co-infection in a 9-year-old with B-cell acute lymphoblastic leukemia
This case report highlights the infrequent occurrence of coinfection involving invasive aspergillosis and Mycobacterium tuberculosis (MTB) in pediatric patients. We present the case of a 9-year-old Thai girl diagnosed with B-cell acute lymphoblastic leukemia, who experienced prolonged febrile neutropenia lasting 1 month during chemotherapy. Chest computed tomography (CT) revealed lung nodules with an air crescent sign, while CT angiography of the brain detected an infected ruptured brain aneurysm, which exhibited septate hyphae with acute angle branching, consistent with invasive aspergillosis. Despite voriconazole treatment, the patient’s high-grade fever and dyspnea persisted. Further investigations revealed a lung abscess and wedge resection confirmed AFB 1+ and positive MTB detection via polymerase chain reaction, leading to the initiation of combined treatment for pulmonary tuberculosis and invasive aspergillosis. Considering drug–drug interactions was an essential aspect of the management. This case report highlights challenges of coinfection between invasive aspergillosis and MTB.
- 1 August 2023
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2023 (8) , 295-297
Open AccessAspergillosis and pulmonary tuberculosis co-infection in a 9-year-old with B-cell acute lymphoblastic leukemia
This case report highlights the infrequent occurrence of coinfection involving invasive aspergillosis and Mycobacterium tuberculosis (MTB) in pediatric patients. We present the case of a 9-year-old Thai girl diagnosed with B-cell acute lymphoblastic leukemia, who experienced prolonged febrile neutropenia lasting 1 month during chemotherapy. Chest computed tomography (CT) revealed lung nodules with an air crescent sign, while CT angiography of the brain detected an infected ruptured brain aneurysm, which exhibited septate hyphae with acute angle branching, consistent with invasive aspergillosis. Despite voriconazole treatment, the patient’s high-grade fever and dyspnea persisted. Further investigations revealed a lung abscess and wedge resection confirmed AFB 1+ and positive MTB detection via polymerase chain reaction, leading to the initiation of combined treatment for pulmonary tuberculosis and invasive aspergillosis. Considering drug–drug interactions was an essential aspect of the management. This case report highlights challenges of coinfection between invasive aspergillosis and MTB.